These results indicate that the EphrinB/SHP2 and Ang2/TIE2 pathways are active in the vasculature of human melanoma and colon carcinoma and that high expression of ANGPT2 alone or with high VEGF‐A in these cancers predicts a worse patient survival probability. The gene discussed is ANGPT2; the disease is colon carcinoma.